{"id":355677,"date":"2025-08-19T02:24:15","date_gmt":"2025-08-19T02:24:15","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/355677\/"},"modified":"2025-08-19T02:24:15","modified_gmt":"2025-08-19T02:24:15","slug":"u-s-patients-can-now-get-ozempic-for-half-price-if-they-can-pay-cash-ctv-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/355677\/","title":{"rendered":"U.S. patients can now get Ozempic for half price if they can pay cash – CTV News"},"content":{"rendered":"
    \n
  1. U.S. patients can now get Ozempic for half price if they can pay cash<\/a>  CTV News<\/li>\n
  2. Drugmaker halves price of Ozempic for Americans amid Trump crackdown<\/a>  The Telegraph<\/li>\n
  3. Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients<\/a>  CNBC<\/li>\n
  4. GoodRx stock soars after striking deal to sell Novo Nordisk’s GLP-1s for $499\/month<\/a>  Yahoo Finance<\/li>\n
  5. Novo Nordisk halves US price of Ozempic<\/a>  Financial Times<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"U.S. patients can now get Ozempic for half price if they can pay cash  CTV News Drugmaker halves price…\n","protected":false},"author":2,"featured_media":355678,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[834,105,4326,16,15],"class_list":{"0":"post-355677","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-apple-news","9":"tag-health","10":"tag-medication","11":"tag-uk","12":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115053059240560866","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/355677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=355677"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/355677\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/355678"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=355677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=355677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=355677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}